دورية أكاديمية
Race, trust, and COVID-19 vaccine hesitancy in people with opioid use disorder.
| العنوان: | Race, trust, and COVID-19 vaccine hesitancy in people with opioid use disorder. |
|---|---|
| المؤلفون: | Sullivan MC; Institute for Collaboration on Health, Intervention, and Policy (InCHIP), University of Connecticut., Mistler C; Institute for Collaboration on Health, Intervention, and Policy (InCHIP), University of Connecticut., Copenhaver MM; Institute for Collaboration on Health, Intervention, and Policy (InCHIP), University of Connecticut., Wickersham JA; Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale School of Medicine., Ni Z; Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale School of Medicine., Kim RS; Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale School of Medicine., Shrestha R; Institute for Collaboration on Health, Intervention, and Policy (InCHIP), University of Connecticut. |
| المصدر: | Health psychology : official journal of the Division of Health Psychology, American Psychological Association [Health Psychol] 2022 Feb; Vol. 41 (2), pp. 115-120. Date of Electronic Publication: 2021 Dec 02. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: American Psychological Association, Division of Health Psychology Country of Publication: United States NLM ID: 8211523 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1930-7810 (Electronic) Linking ISSN: 02786133 NLM ISO Abbreviation: Health Psychol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Washington, DC : American Psychological Association, Division of Health Psychology Original Publication: Hillsdale, N.J. : Lawerence Erlbaum Associates, c1982- |
| مواضيع طبية MeSH: | COVID-19*/prevention & control , Opioid-Related Disorders*/epidemiology, Adult ; COVID-19 Vaccines ; Female ; Humans ; Male ; Pandemics/prevention & control ; SARS-CoV-2 ; Trust ; Vaccination ; Vaccination Hesitancy |
| مستخلص: | Objective: Vaccination against coronavirus disease 2019 (COVID-19) is a promising avenue for arresting the COVID-19 pandemic, yet suboptimal rates of vaccine uptake in at-risk groups may hinder efficacy and worsen existing health disparities. People with opioid use disorder (OUD) are likely to face increased vulnerability to COVID-19 due to a confluence of biological and social risk factors. We sought to assess factors associated with willingness to vaccinate against COVID-19 in people with OUD. Method: Phone surveys were conducted from May to October 2020 with participants enrolled in an urban methadone maintenance program (MMP). Participants were adults who met DSM-5 criteria for OUD and reported injection drug use or sexual risk behavior. Participants were asked about their willingness to receive a highly or partially effective vaccine. Provider trust was assessed using the Trust in Physician scale. Multinomial regression was used to assess demographic and psychosocial factors related to vaccination willingness. Results: We surveyed 109 people with OUD enrolled in a MMP ( M = 47 years; 56% women; 59% White, 23% Black/African American, 14.4% Hispanic/Latinx; 1.8% other). Participants who identified as Black or African American were significantly less likely to endorse willingness to use a partially effective COVID-19 vaccine (adjusted odds ratio [ aOR ] = .10; 95% confidence interval (CI) [.02, .61], p = .012), although not necessarily less willing to receive a highly effective vaccine ( aOR = .40; 95% CI [.09, 1.73], p = .219; n.s .). Trust in physician was positively associated with willingness to use a partially effective vaccine ( aOR = 1.12; 95% CI [1.02, 1.23], p = .017), but was not significantly associated with willingness to receive a highly effective vaccine ( aOR = 1.07; 95% CI [.98, 1.16], p = .162, n.s ) Conclusions: Proactive outreach from trustworthy sources will be needed to counter vaccine hesitancy in people with OUD, especially among Black Americans with OUD. (PsycInfo Database Record (c) 2022 APA, all rights reserved). |
| References: | J Health Soc Behav. 2014 Mar;55(1):3-19. (PMID: 24578393) Drug Alcohol Depend. 2021 Feb 1;219:108477. (PMID: 33422864) Am J Prev Med. 2020 Oct;59(4):493-503. (PMID: 32778354) N Engl J Med. 2020 Oct 1;383(14):1296-1299. (PMID: 32589371) J Community Health. 2021 Oct;46(5):960-966. (PMID: 33770334) BMC Med. 2019 Feb 15;17(1):7. (PMID: 30764816) Immunity. 2020 May 19;52(5):737-741. (PMID: 32433946) Am J Community Psychol. 2010 Mar;45(1-2):87-106. (PMID: 20077134) N Engl J Med. 2020 Dec 31;383(27):2603-2615. (PMID: 33301246) Annu Rev Public Health. 2006;27:1-28. (PMID: 16533107) Addict Sci Clin Pract. 2021 Jan 7;16(1):4. (PMID: 33413619) JAMA. 2020 Jun 23;323(24):2458-2459. (PMID: 32421155) Health Behav Policy Rev. 2020 Oct;7(5):489-497. (PMID: 33134405) Subst Use Misuse. 2020;55(11):1900-1901. (PMID: 32657207) Drug Alcohol Depend. 2021 Mar 1;220:108519. (PMID: 33461150) Med Care. 1999 May;37(5):510-7. (PMID: 10335753) Mol Psychiatry. 2021 Jan;26(1):30-39. (PMID: 32929211) Nat Rev Drug Discov. 2020 May;19(5):305-306. (PMID: 32273591) N Engl J Med. 2021 Feb 4;384(5):403-416. (PMID: 33378609) J Gerontol B Psychol Sci Soc Sci. 2021 Feb 17;76(3):e75-e80. (PMID: 32756973) J Subst Abuse Treat. 2021 Oct;129:108387. (PMID: 34080555) J Acquir Immune Defic Syndr. 2021 Feb 1;86(2):200-207. (PMID: 33196555) Behav Res Methods. 2007 May;39(2):175-91. (PMID: 17695343) N Engl J Med. 2020 Sep 17;383(12):e77. (PMID: 32706952) Psychol Rep. 1990 Dec;67(3 Pt 2):1091-100. (PMID: 2084735) Ann Intern Med. 2020 Jul 7;173(1):61-62. (PMID: 32240293) J Gen Intern Med. 2010 Dec;25(12):1300-8. (PMID: 20714819) Am J Public Health. 1997 Nov;87(11):1773-8. (PMID: 9366634) J Subst Abuse Treat. 2020 Oct;117:108058. (PMID: 32811633) J Racial Ethn Health Disparities. 2022 Feb;9(1):236-246. (PMID: 33469868) JAMA. 2020 Jun 23;323(24):2466-2467. (PMID: 32391864) |
| معلومات مُعتمدة: | R21 DA051934 United States DA NIDA NIH HHS; K24 DA051344 United States DA NIDA NIH HHS; T32 MH074387 United States MH NIMH NIH HHS; R01 DA032290 United States DA NIDA NIH HHS; K01 DA038529 United States DA NIDA NIH HHS; K01 DA051346 United States DA NIDA NIH HHS |
| المشرفين على المادة: | 0 (COVID-19 Vaccines) |
| تواريخ الأحداث: | Date Created: 20211202 Date Completed: 20220307 Latest Revision: 20240102 |
| رمز التحديث: | 20240103 |
| مُعرف محوري في PubMed: | PMC9754617 |
| DOI: | 10.1037/hea0001120 |
| PMID: | 34855415 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1930-7810 |
|---|---|
| DOI: | 10.1037/hea0001120 |